HOLLYNS HEALTH & WELLBEING — All Prescriptions & Medications — Page 6
Practice Code: B83045 | BRADFORD, BD14 6NF
Showing results 251-300 of 703
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Lymecycline | 129 | 7,420 | £856 | +7.2% ▲ |
| Hydrocortisone | 128 | 15.7K | £16.3K | +51.6% ▲ |
| Lidocaine hydrochloride | 128 | 1,267 | £1.9K | -25.8% ▼ |
| Ibandronic acid | 127 | 2,297 | £2.2K | +249.5% ▲ |
| Fesoterodine fumarate | 127 | 3,304 | £286 | +222.0% ▲ |
| Midodrine hydrochloride | 126 | 17.0K | £4.3K | +158.6% ▲ |
| Tirzepatide | 126 | 135 | £12.6K | -35.1% ▼ |
| Theophylline | 125 | 5,026 | £2.5K | +49.5% ▲ |
| Amisulpride | 125 | 6,192 | £1.2K | +77.8% ▲ |
| Co-beneldopa (Benserazide/levodopa) | 125 | 18.7K | £1.2K | -17.3% ▼ |
| Enalapril maleate | 122 | 3,857 | £426 | -32.1% ▼ |
| Valproic acid | 122 | 8,370 | £2.8K | +40.2% ▲ |
| Bimatoprost | 122 | 1,395 | £1.9K | -17.9% ▼ |
| Metoprolol tartrate | 121 | 7,154 | £931 | +138.6% ▲ |
| Duloxetine hydrochloride | 121 | 6,762 | £1.3K | +136.1% ▲ |
| Typhoid | 121 | 121 | £1.3K | +34.4% ▲ |
| Carbimazole | 119 | 7,559 | £1.7K | +5.3% ▲ |
| Tacrolimus | 119 | 7,850 | £10.8K | +344.9% ▲ |
| Tacrolimus | 119 | 4,380 | £3.4K | +120.7% ▲ |
| Methylphenidate hydrochloride | 117 | 5,501 | £6.3K | -54.7% ▼ |
| Nicotine | 117 | 4,012 | £3.4K | +107.1% ▲ |
| Fenofibrate | 115 | 3,437 | £414 | +18.8% ▲ |
| Fluticasone propionate (Nasal) | 115 | 274 | £1.4K | -21.0% ▼ |
| Insulin Lispro | 110 | 1,000 | £7.4K | +43.8% ▲ |
| Fusidic acid | 110 | 2,055 | £266 | -13.9% ▼ |
| 110 | 66.9K | £834 | +20.6% ▲ | |
| Oxybutynin | 109 | 6,790 | £1.3K | -42.8% ▼ |
| Betamethasone esters | 109 | 15.4K | £1.4K | +80.7% ▲ |
| 109 | 6,290 | £295 | +100.8% ▲ | |
| Clonidine hydrochloride | 108 | 12.8K | £3.1K | +102.4% ▲ |
| Fluticasone propionate/azelastine hydrochloride (Nasal) | 107 | 107 | £1.5K | -5.7% ▼ |
| Alfacalcidol | 106 | 4,640 | £685 | -14.3% ▼ |
| Clotrimazole | 105 | 2,390 | £143 | +8.4% ▲ |
| RtS 2.4 kcal/ml m/sk lower volume, higher protein (0913011) | 103 | 268.5K | £5.4K | +47.2% ▲ |
| Semaglutide | 102 | 3,786 | £12.4K | -57.6% ▼ |
| Anastrozole | 102 | 4,522 | £172 | +12.0% ▲ |
| Co-amoxiclav (Amoxicillin/clavulanic acid) | 101 | 4,915 | £424 | -33.9% ▼ |
| Letrozole | 101 | 3,474 | £399 | -45.9% ▼ |
| Ascorbic acid | 101 | 1,057 | £1.7K | +391.9% ▲ |
| Neomycin sulfate | 101 | 1,530 | £194 | +70.4% ▲ |
| Colchicine | 100 | 3,493 | £71 | +28.2% ▲ |
| Dosulepin hydrochloride | 99 | 7,560 | £1.6K | +74.9% ▲ |
| Magnesium citrate | 95 | 5,811 | £7.1K | +1,213.9% ▲ |
| Atomoxetine hydrochloride | 94 | 2,149 | £4.6K | +178.0% ▲ |
| Fluconazole | 94 | 1,443 | £239 | +21.6% ▲ |
| Sodium feredetate | 93 | 39.3K | £1.1K | +224.7% ▲ |
| 93 | 152 | £21.8K | +160.4% ▲ | |
| Ranolazine | 92 | 6,248 | £1.1K | -45.9% ▼ |
| Metoclopramide hydrochloride | 91 | 7,233 | £558 | +9.8% ▲ |
| Biphasic insulin aspart | 91 | 944 | £5.6K | -10.4% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.